How Prolonged Exposure to TNF-Alpha and IL-6 Impacts Neural Activity and Cognitive Function in Long COVID

Medical News: A groundbreaking study conducted by researchers from Lawrence Livermore National Laboratory in the United States has shed new light on how long COVID affects brain function. The study specifically focused on the impact of prolonged inflammation caused by two key cytokines, tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), on neural activity. These inflammatory molecules are found at elevated levels in individuals suffering from long COVID and other post-viral syndromes such as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The research team utilized advanced neural cell culture models to study how long-term exposure to these cytokines alters brain cell behavior, potentially contributing to the cognitive impairment reported by long COVID patients.


How Prolonged Exposure to TNF-Alpha and IL-6 Impacts Neural Activity and Cognitive Function in Long COVID

The Mechanism Behind Long COVID Brain Fog
Cognitive dysfunction is one of the most persistent and debilitating symptoms of long COVID. Many individuals experience memory problems, brain fog, difficulty concentrating, and even mood disorders. While researchers have long suspected that immune system dysfunction plays a role in these symptoms, the precise biological mechanisms remain largely unknown. This Medical News report highlights how the new study addresses these knowledge gaps by examining the direct effects of TNF-α and IL-6 on neurons and astrocytes, the two main types of brain cells responsible for processing and supporting neural activity.
 
Using human-induced pluripotent stem cell (iPSC)-derived neurons and astrocytes grown in a laboratory setting, the scientists observed how exposure to TNF-α and IL-6 affected brain cell communication over time. By mimicking real-life conditions seen in long COVID patients, the study revealed that prolonged exposure to these cytokines leads to disruptions in neural signaling, reduced brain cell activity, and potential long-term damage to cognitive functions.
 
Key Findings of the Study
1. TNF-α and IL-6 Affect Brain Cell Communication
The study found that TNF-α and IL-6 impact neural activity in a concentration-dependent manner. Lower levels of TNF-α altered neural firing rates and burst patterns without causing immediate damage, while higher levels significantly reduced neural activity and impaired the ability of brain cells to communicate effectively. IL-6, on the other hand, primarily affected the duration and frequency of neural bursts, further exacerbating cognitive dysfunction.
 
2. High Levels of TNF-α Reduce Brain Cell Function
When brain cells were exposed to high concentrations of TNF-α for prolonged periods, their activity significantly decreased. This reduction in neural function suggests that chronic inflammation could be directly impairing cognitive abilities in long COVID patients. The study also observed a reduction in the ability of neurons to synchroniz e and form stable network connections, which is crucial for learning and memory functions.
 
3. IL-6 Contributes to the Breakdown of Neural Networks
Unlike TNF-α, which primarily reduced overall neural activity, IL-6 played a role in modifying the pattern of neural bursts. These bursts are essential for processing and transmitting information in the brain. The study found that IL-6 exposure led to shorter bursts, which suggests a disruption in the normal neural communication required for cognitive tasks such as attention and memory retention.
 
4. Combination of TNF-α and IL-6 Worsens the Effects
The researchers also studied how TNF-α and IL-6 interact when present together, as is often the case in long COVID patients. They found that while IL-6 sometimes counteracted the effects of TNF-α at lower concentrations, higher levels of both cytokines led to severe disruptions in neural function. This suggests that chronic inflammation involving multiple cytokines could be one of the leading causes of persistent cognitive impairment in long COVID sufferers.
 
Implications for Long COVID Treatment
The findings from this study have significant implications for how long COVID-related cognitive impairment is treated. By identifying TNF-α and IL-6 as key players in neural dysfunction, scientists can now explore targeted therapies that aim to reduce these inflammatory molecules. This could involve the use of anti-inflammatory drugs, immune-modulating therapies, or lifestyle changes that help control inflammation in the body.
 
Additionally, the study highlights the importance of further research into the long-term consequences of chronic inflammation on the brain. While current treatments for long COVID focus primarily on symptom management, future therapies may need to address underlying immune system imbalances to restore proper brain function.
 
The Need for More Research
Although this study provides crucial insights into the biological effects of TNF-α and IL-6 on brain function, more research is needed to fully understand the broader implications. Future studies could examine whether similar inflammatory processes occur in other neurological conditions such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis.
 
Moreover, research into potential interventions is urgently needed. Clinical trials investigating drugs that can specifically target TNF-α and IL-6 may provide promising treatment options for those suffering from long COVID. In the meantime, strategies such as maintaining a healthy diet, regular exercise, and stress management techniques may help mitigate inflammation and improve cognitive function in affected individuals.
 
Conclusion
The study findings provide compelling evidence that prolonged exposure to TNF-α and IL-6 significantly affects neural activity, potentially contributing to the cognitive impairment seen in long COVID patients. The findings emphasize the need for targeted therapeutic strategies to reduce inflammation and protect brain health. As research continues, understanding how these inflammatory pathways operate could lead to new breakthroughs in the treatment of long COVID and other neuroinflammatory disorders.
 
The study findings were published in the peer-reviewed journal: Frontiers in Cellular Neuroscience.
https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2025.1512591/full
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/enlarged-perivascular-spaces-in-the-brain-linked-to-neuropsychiatric-symptoms-in-long-covid
 
https://www.thailandmedical.news/news/how-neurotropic-viruses-such-as-influenza-hiv-herpes-affect-the-human-brain-to-cause-neuropsychiatric-disorders
 
https://www.thailandmedical.news/news/sars-cov-2-infects-microglia-the-immune-cells-of-the-brain-affecting-long-term-cerebrum-health
 
https://www.thailandmedical.news/articles/coronavirus
 
https://www.thailandmedical.news/articles/long-covid
 
https://www.thailandmedical.news/pages/thailand_doctors_listings